ACS Infect. Dis. 2021
Screening our FDA-Approved and Bioactive Compounds Library for Antiviral Activity against SARS-CoV‑2
We identified 13 compounds that exhibit potent antiviral activity across multiple orthogonal assays. Hits include known antivirals, compounds with anti-inflammatory activity, and compounds targeting host pathways such as kinases and proteases critical for SARS-CoV-2 replication.